|
PHTF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.85719999999635E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.70252999999176E-05 |
| Normal-vs-Stage2 |
2.641200E-04 |
| Normal-vs-Stage3 |
7.179400E-03 |
| Normal-vs-Stage4 |
2.190400E-02 |
| Stage1-vs-Stage2 |
5.269000E-01 |
| Stage1-vs-Stage3 |
3.916800E-01 |
| Stage1-vs-Stage4 |
2.546400E-01 |
| Stage2-vs-Stage3 |
2.532800E-01 |
| Stage2-vs-Stage4 |
1.943180E-01 |
| Stage3-vs-Stage4 |
8.250800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.553300E-04 |
| Normal-vs-AfricanAmerican |
2.208400E-01 |
| Normal-vs-Asian |
4.864200E-03 |
| Caucasian-vs-AfricanAmerican |
2.142400E-01 |
| Caucasian-vs-Asian |
7.436800E-01 |
| AfricanAmerican-vs-Asian |
3.018800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.998000E-03 |
| Normal-vs-Female |
3.81360000000219E-05 |
| Male-vs-Female |
5.170200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.627800E-04 |
| Normal-vs-Age(41-60Yrs) |
7.47540000012314E-07 |
| Normal-vs-Age(61-80Yrs) |
1.275690E-02 |
| Normal-vs-Age(81-100Yrs) |
2.652600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.432050E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.948400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.785000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.559600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.260000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.541000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.924600E-01 |
| Classical-VS-Follicular |
2.253700E-02 |
| Classical-VS-Other |
1.670200E-01 |
| Classical-VS-Normal |
1.322580E-03 |
| Tall-VS-Follicular |
2.620000E-01 |
| Tall-VS-Other |
2.671400E-01 |
| Tall-VS-Normal |
2.368300E-02 |
| Follicular-VS-Other |
6.898000E-01 |
| Follicular-VS-Normal |
7.9703000000042E-05 |
| Other-VS-Normal |
1.172150E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.40740000001516E-06 |
| Normal-vs-N1 |
3.739600E-03 |
| N0-vs-N1 |
2.024400E-01 |
|
|
